F18ac + non-enterotoxigenic Escherichia by Ana Kovšca Janjatović et al.
77
ISSN 0372-5480
Printed in Croatia
VETERINARSKI ARHIV 81 (1), 77-90, 2011
De novo  De novo differentiation of intestinal villous M cells in weaned pigs  differentiation of intestinal villous M cells in weaned pigs 
immunized with levamisole-adjuvanted vaccine candidate F4ac immunized with levamisole-adjuvanted vaccine candidate F4ac+ + or   or 
F18ac F18ac+  + non-enterotoxigenic  non-enterotoxigenic Escherichia coli  Escherichia coli strains strains
Ana Kovšca Janjatović Ana Kovšca Janjatović1 1, Gordana Lacković , Gordana Lacković2 2, Frane Božić , Frane Božić3 3,  , 
Hrvoje Valpotić Hrvoje Valpotić4 4, Mirna Tominac-Trcin , Mirna Tominac-Trcin5 5, Srećko Sladoljev , Srećko Sladoljev6 6, Branka Šeol , Branka Šeol7 7,  , 
Ivica Valpotić Ivica Valpotić1 1*, and Maja Popović *, and Maja Popović1 1
1 1Department of Biology, Faculty of Veterinary Medicine, University of Zagreb, Croatia Department of Biology, Faculty of Veterinary Medicine, University of Zagreb, Croatia
2 2Department of Zoology, Division of Biology, Faculty of Science, University of Zagreb, Croatia Department of Zoology, Division of Biology, Faculty of Science, University of Zagreb, Croatia
3 3Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Zagreb, Croatia Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Zagreb, Croatia
4 4Department of Animal Nutrition, Faculty of Veterinary Medicine, University of Zagreb, Croatia Department of Animal Nutrition, Faculty of Veterinary Medicine, University of Zagreb, Croatia
5 5Clinic for Traumathology, Medical Faculty, University of Zagreb, Croatia Clinic for Traumathology, Medical Faculty, University of Zagreb, Croatia
6 6Institute of Immunology, Zagreb, Croatia Institute of Immunology, Zagreb, Croatia
7 7Department of Microbiology and Infectious Diseases, Faculty of Veterinary Medicine, University of Zagreb, Croatia Department of Microbiology and Infectious Diseases, Faculty of Veterinary Medicine, University of Zagreb, Croatia
KOVŠCA  JANJATOVIĆ,  A.,  G.  LACKOVIĆ,  F.  BOŽIĆ,  H.  VALPOTIĆ,  M.  KOVŠCA JANJATOVIĆ, A., G. LACKOVIĆ, F. BOŽIĆ, H. VALPOTIĆ, M. 
TOMINAC-TRCIN,  S.  SLADOLJEV,  B.  ŠEOL,  I.  VALPOTIĆ,  M.  POPOVIĆ: TOMINAC-TRCIN, S. SLADOLJEV, B. ŠEOL, I. VALPOTIĆ, M. POPOVIĆ:   
De novo  De novo differentiation of intestinal villous M cells in weaned pigs immunized with  differentiation of intestinal villous M cells in weaned pigs immunized with 
levamisole-adjuvanted  vaccine  candidate  F4ac levamisole-adjuvanted vaccine candidate F4ac+ +  or  F18ac  or F18ac+  +  non-enterotoxigenic  non-enterotoxigenic 
Escherichia coli  Escherichia coli strains strains. .   Vet. arhiv 81, 77-90, 2011. Vet. arhiv 81, 77-90, 2011.
ABSTRACT ABSTRACT
Active  immunization  against  porcine  postweaning  colidiarrhea  (CD)  and/or  colienterotoxemia  (CE)  Active immunization against porcine postweaning colidiarrhea (CD) and/or colienterotoxemia (CE) 
caused by F4 caused by F4+ + and/or F18  and/or F18+ + enterotoxigenic   enterotoxigenic Escherichia coli Escherichia coli (ETEC) is still an unsolved problem. The intestinal   (ETEC) is still an unsolved problem. The intestinal 
microfold (M) cells play a role in the entry/invasion of intraluminal pathogens (such as ETEC strains), in  microfold (M) cells play a role in the entry/invasion of intraluminal pathogens (such as ETEC strains), in 
antigen sampling, and in facilitating the induction of immunity to gut infections. Just as ETEC strains can  antigen sampling, and in facilitating the induction of immunity to gut infections. Just as ETEC strains can 
exploit M cells as the portal of entry for infections, such as CD and/or CE, their high transcytotic ability  exploit M cells as the portal of entry for infections, such as CD and/or CE, their high transcytotic ability 
makes them an attractive target for mucosally delivered vaccines, adjuvants and therapeutics. The objective of  makes them an attractive target for mucosally delivered vaccines, adjuvants and therapeutics. The objective of 
our study was to evaluate the effects of levamisole-adjuvanted vaccine candidate F4ac our study was to evaluate the effects of levamisole-adjuvanted vaccine candidate F4ac+  + and F18ac and F18ac+ +non-ETEC  non-ETEC 
strains on incidence/frequency of ileal M cells and up-regulation of antigen delivery by  strains on incidence/frequency of ileal M cells and up-regulation of antigen delivery by de novo de novo formation of   formation of 
these cells in weaned pigs. Conventionally reared 4-week-old pigs were divided into three groups, of which  these cells in weaned pigs. Conventionally reared 4-week-old pigs were divided into three groups, of which 
two were parenterally and orally immunized with levamisole (at days -2, -1 and 0) in combination with either  two were parenterally and orally immunized with levamisole (at days -2, -1 and 0) in combination with either 
vaccine candidate non-ETEC strain (at day 0), respectively. The third group of pigs received saline as a placebo.  vaccine candidate non-ETEC strain (at day 0), respectively. The third group of pigs received saline as a placebo. 
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Challenge was performed (at day 7) with the F4ac Challenge was performed (at day 7) with the F4ac+  + ETEC strain, and the pigs were euthanatized (at day 13) and  ETEC strain, and the pigs were euthanatized (at day 13) and 
sampled for immunohistology. Distribution patterns of cytokeratin 18 positive M cells revealed that they are  sampled for immunohistology. Distribution patterns of cytokeratin 18 positive M cells revealed that they are 
interspersed between enterocytes than as small clusters, and most of them were found to be located at the apex  interspersed between enterocytes than as small clusters, and most of them were found to be located at the apex 
of the villi in the ileum of 6-weeks-old-pigs. Morphometric quantiﬁ  cation of M cells in the ileal mucosa showed  of the villi in the ileum of 6-weeks-old-pigs. Morphometric quantiﬁ  cation of M cells in the ileal mucosa showed 
that  levamisole-pretreated  F18ac that levamisole-pretreated F18ac+ +non-ETEC-immunized non-ETEC-immunized    and  challenged  pigs  had  signiﬁ  cantly  increased  and challenged pigs had signiﬁ  cantly  increased 
numbers (P<0.01) of ileal M cells as compared to the values obtained in the control non-primed and challenged  numbers (P<0.01) of ileal M cells as compared to the values obtained in the control non-primed and challenged 
pigs. The proportion of these cells in this group of pigs was increased by 145%. In the levamisole-pretreated  pigs. The proportion of these cells in this group of pigs was increased by 145%. In the levamisole-pretreated 
F4ac F4ac+ + non-ETEC-immunized  non-ETEC-immunized   and challenged pigs only a slightly increased (for 7%) proportion of M cells was  and challenged pigs only a slightly increased (for 7%) proportion of M cells was 
recorded. However, this increase was not signiﬁ  cantly different from the numerical values obtained for control  recorded. However, this increase was not signiﬁ  cantly different from the numerical values obtained for control 
pigs. Our ﬁ  nding that levamisole-adjuvanted F18ac pigs. Our ﬁ  nding that levamisole-adjuvanted F18ac+ +non-ETEC vaccine may affect  non-ETEC vaccine may affect de novo de novo differentiation of   differentiation of 
antigen-sampling M cells by increasing their number in the ileum, indicated that the vaccine probably utilizes  antigen-sampling M cells by increasing their number in the ileum, indicated that the vaccine probably utilizes 
these cells as a target for entry/delivery to the nearby lymphocytes and induces protective immunity against CE.  these cells as a target for entry/delivery to the nearby lymphocytes and induces protective immunity against CE. 
On the other hand, the failure of levamisole-adjuvanted F4ac On the other hand, the failure of levamisole-adjuvanted F4ac+ +non-ETEC vaccine to produce a similar effect on  non-ETEC vaccine to produce a similar effect on 
M cells remains to be elucidated.  M cells remains to be elucidated. 
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Introduction Introduction
The abnormal colonization pattern of the small intestine by F4ac The abnormal colonization pattern of the small intestine by F4ac+ + and/or F18ac  and/or F18ac+ +   
enterotoxigenic  enterotoxigenic Escherichia coli Escherichia coli (ETEC) strains was recognized as a characteristic of   (ETEC) strains was recognized as a characteristic of 
the commonly occurring postweaning colidiarrhea (CD) and/or colienterotoxemia (CE)  the commonly occurring postweaning colidiarrhea (CD) and/or colienterotoxemia (CE) 
in newly weaned pigs, aging between 4 and 12 weeks ( in newly weaned pigs, aging between 4 and 12 weeks (NAGY and FEKETE, 1999 NAGY and FEKETE, 1999). These  ). These 
infections are the most important cause of economic losses in the swine industry due to  infections are the most important cause of economic losses in the swine industry due to 
morbidity, decreased growth rate, cost of medication, and mortality. To date, none of  morbidity, decreased growth rate, cost of medication, and mortality. To date, none of 
the preventive strategies applied ( the preventive strategies applied (FAIRBROTHER et al., 2005 FAIRBROTHER et al., 2005) has been able to efﬁ  ciently  ) has been able to efﬁ  ciently 
protect  pigs  from  CD  and/or  CE.  One  of  the  most  promising  immunoprophylactic  protect pigs from CD and/or CE. One of the most promising immunoprophylactic 
approaches to prevention and control of these infections includes oral immunization of  approaches to prevention and control of these infections includes oral immunization of 
pigs before weaning with live avirulent non-ETEC strains carrying ﬁ  mbrial adhesins,  pigs before weaning with live avirulent non-ETEC strains carrying ﬁ  mbrial adhesins, 
homologous to those of ETEC strains present in the given swine population ( homologous to those of ETEC strains present in the given swine population (NAGY and  NAGY and 
FEKETE, 2005 FEKETE, 2005).  ). 
However, the successful mucosal vaccines against CD and/or CE must circumvent  However, the successful mucosal vaccines against CD and/or CE must circumvent 
the same barriers that enteric pathogens have,  the same barriers that enteric pathogens have, i.e. i.e. mucus, proteases, nucleases, secretory   mucus, proteases, nucleases, secretory 
IgA antibodies, and the epithelial glycocalyx ( IgA antibodies, and the epithelial glycocalyx (MILLER et al., 2007 MILLER et al., 2007). Enteric pathogens  ). Enteric pathogens 
themselves, such as ETEC strains, have so far been the most effective immunogens  themselves, such as ETEC strains, have so far been the most effective immunogens 
exploited for mucosal vaccination. ( exploited for mucosal vaccination. (COX et al., 2002; VERDONCK et al., 2002 COX et al., 2002; VERDONCK et al., 2002). Just as an  ). Just as an 
ETEC can exploit intestinal microfolds (M) as the portal of entry for infection, researchers  ETEC can exploit intestinal microfolds (M) as the portal of entry for infection, researchers 
have investigated the potential of using M cell-speciﬁ  c mechanisms for drug or vaccine  have investigated the potential of using M cell-speciﬁ  c mechanisms for drug or vaccine 
delivery to the mucosal immune system ( delivery to the mucosal immune system (BRAYDEN and BAIRD, 2004; KUOLEE and CHEN,  BRAYDEN and BAIRD, 2004; KUOLEE and CHEN, 
2008 2008). Upon M cells-mediated antigen sampling at the interface of epithelial surfaces  ). Upon M cells-mediated antigen sampling at the interface of epithelial surfaces 
and the intraluminal environment, the intestinal mucosal immune system can actively  and the intraluminal environment, the intestinal mucosal immune system can actively 
discriminate between harmful pathogenic bacteria and their products and harmless dietary  discriminate between harmful pathogenic bacteria and their products and harmless dietary 
antigens, resulting in either protective immune responses or oral tolerance, respectively  antigens, resulting in either protective immune responses or oral tolerance, respectively 79
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( (STOKES and BAILEY, 1994; STOKES and BAILEY, 1996 STOKES and BAILEY, 1994; STOKES and BAILEY, 1996) ).  . Although the Although the   intestinal mucosal  intestinal mucosal 
immune system has the ability to recognize these different groups of antigens and has  immune system has the ability to recognize these different groups of antigens and has 
evolved a battery of immune cells/molecules, which may orchestrate an appropriate  evolved a battery of immune cells/molecules, which may orchestrate an appropriate 
response, it is paradoxical that the question as to how this system selects a particular  response, it is paradoxical that the question as to how this system selects a particular 
response still remains largely unanswered ( response still remains largely unanswered (STOKES et al., 2004; BAILEY et al., 2005 STOKES et al., 2004; BAILEY et al., 2005). ).   This  This 
is the is the   main obstacle for the development of safe and effective vaccines against porcine  main obstacle for the development of safe and effective vaccines against porcine 
post-weaning CD and/or CE. The potential of immunomodulators/adjuvants being used  post-weaning CD and/or CE. The potential of immunomodulators/adjuvants being used 
therapeutically, not only to reconstitute defective responses, such as in immunologically  therapeutically, not only to reconstitute defective responses, such as in immunologically 
compromised or immature newly weaned pigs, but also to enhance normal responses  compromised or immature newly weaned pigs, but also to enhance normal responses 
to target antigens at intestinal mucosal sites, to target antigens at intestinal mucosal sites,   is now an attractive approach for mucosal  is now an attractive approach for mucosal 
vaccine design ( vaccine design (HUSBAN HUSBAND D et al., 1999  et al., 1999). Also, such an approach ). Also, such an approach   includes the use of  includes the use of 
adjuvants ( adjuvants (HOLMGREN et al HOLMGREN et al., ., 2003  2003), particularly levamisole ( ), particularly levamisole (CHEN et al., 2008 CHEN et al., 2008) which  ) which 
has exhibited potentials as an immunomodulator and mucosal adjuvant when applied  has exhibited potentials as an immunomodulator and mucosal adjuvant when applied 
alone or in combination with live oral vaccines against CD and/or CE ( alone or in combination with live oral vaccines against CD and/or CE (BOŽIĆ et al., 2002;  BOŽIĆ et al., 2002; 
BOŽIĆ et al., BOŽIĆ et al.,   2003a, b; BOŽIĆ et al., 2006; JANJATOVIĆ et al 2003a, b; BOŽIĆ et al., 2006; JANJATOVIĆ et al., ., 2008; KOVŠCA JANJATOVIĆ   2008; KOVŠCA JANJATOVIĆ 
et al., et al.,   2009 2009). More recent ﬁ  ndings that levamisole may affect  ). More recent ﬁ  ndings that levamisole may affect de novo de novo differentiation of   differentiation of 
antigen-sampling M cells by increasing their numbers in the ileum of weaned pigs, make  antigen-sampling M cells by increasing their numbers in the ileum of weaned pigs, make 
it an interesting adjuvant to study the development of an effective M cell-targeted vaccine  it an interesting adjuvant to study the development of an effective M cell-targeted vaccine 
against porcine post-weaning CD and/or CE ( against porcine post-weaning CD and/or CE (VALPOTIĆ et al., 2010 VALPOTIĆ et al., 2010). The latter studies  ). The latter studies 
have implied that levamisole may also affect differentiation and proliferation of porcine  have implied that levamisole may also affect differentiation and proliferation of porcine 
M cells by increasing their numbers in the intestinal villous epithelium. Thus, it would  M cells by increasing their numbers in the intestinal villous epithelium. Thus, it would 
be tempting to suggest that our observation of levamisole-stimulated proliferation of the  be tempting to suggest that our observation of levamisole-stimulated proliferation of the 
ileal villous M cells may have some relevance to the process of delivery of new mucosal  ileal villous M cells may have some relevance to the process of delivery of new mucosal 
vaccines against porcine CD and/or CE to the immune cells populating the intestinal  vaccines against porcine CD and/or CE to the immune cells populating the intestinal 
lamina propria.  lamina propria. 
Indeed,  it  has  been  demonstrated  that  M  cells  can  transport  a  diverse  array  of  Indeed, it has been demonstrated that M cells can transport a diverse array of 
intraluminal microorganisms across the intestinal epithelial barrier, including  intraluminal microorganisms across the intestinal epithelial barrier, including E. coli E. coli   
( (GEBERT  et  al GEBERT et al., .,  1996  1996),  but  also  a  variety  of  synthetic  microparticles/nanoparticles  as  ), but also a variety of synthetic microparticles/nanoparticles as 
vehicles for mucosal vaccine delivery ( vehicles for mucosal vaccine delivery (TORCHÉ et al., 2000 TORCHÉ et al., 2000), beta 1 integrins, pathogen  ), beta 1 integrins, pathogen 
recognition receptors, and speciﬁ  c carbohydrate residues ( recognition receptors, and speciﬁ  c carbohydrate residues (KUOLEE and CHEN, 2008 KUOLEE and CHEN, 2008).  ). 
Porcine intestinal M cells may be distinguished from the other cells residing in follicle- Porcine intestinal M cells may be distinguished from the other cells residing in follicle-
associated epithelium (FAE) by the expression of cytokeratin peptide 18 ( associated epithelium (FAE) by the expression of cytokeratin peptide 18 (GEBERT et al.,  GEBERT et al., 
1994 1994). As in rodents and humans (Jang et al., 2004), we have demonstrated ( ). As in rodents and humans (Jang et al., 2004), we have demonstrated (VALPOTIĆ et  VALPOTIĆ et 
al., 2010 al., 2010) that cytokeratin 18 peptide enabled identiﬁ  cation, localization and quantiﬁ  cation  ) that cytokeratin 18 peptide enabled identiﬁ  cation, localization and quantiﬁ  cation 
of intestinal villous M cells within the epithelial layer in the ileal mucosa of weaned  of intestinal villous M cells within the epithelial layer in the ileal mucosa of weaned 
pigs.  pigs. 
Recently we have demonstrated by histomorphometric analyses that levamisole- Recently we have demonstrated by histomorphometric analyses that levamisole-
adjuvanted F18ac adjuvanted F18ac+  + and F4ac and F4ac+ +non-ETEC vaccine candidate strains stimulated lymphoid  non-ETEC vaccine candidate strains stimulated lymphoid 
and myeloid cells residing in the jejunal and ileal mnusosa of weaned pigs ( and myeloid cells residing in the jejunal and ileal mnusosa of weaned pigs (KOVŠCA  KOVŠCA 80
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JANJATOVIĆ et al., JANJATOVIĆ et al.,   2009; KOVŠCA JANJATOVIĆ et al., 2009; KOVŠCA JANJATOVIĆ et al.,   2010 2010). The current study evaluated  ). The current study evaluated 
the effects of levamisole-adjuvanted vaccine candidate F4ac the effects of levamisole-adjuvanted vaccine candidate F4ac+  + and F18ac and F18ac+ +non-ETEC strains  non-ETEC strains 
on the incidence/frequency of ileal M cells and up-regulation of antigen delivery by  on the incidence/frequency of ileal M cells and up-regulation of antigen delivery by de  de 
novo novo formation of these cells in weaned pigs. The main objective was to establish the   formation of these cells in weaned pigs. The main objective was to establish the 
potential of levamisole-adjuvanted vaccine candidate strains in promoting differentiation  potential of levamisole-adjuvanted vaccine candidate strains in promoting differentiation 
of porcine ileal M cell phenotypes as an attractive target for mucosally delivered vaccines  of porcine ileal M cell phenotypes as an attractive target for mucosally delivered vaccines 
against CD and/or CE. against CD and/or CE.   
Materials and methods Materials and methods
Pigs. Pigs. Fifteen crossbred pigs (Swedish Landrace   Fifteen crossbred pigs (Swedish Landrace × × Yorkshire) weighing 6.5   Yorkshire) weighing 6.5 ±  ± 1 kg, the  1 kg, the 
progeny of three litters, were purchased from a swine farm near Zagreb, Croatia. The pigs  progeny of three litters, were purchased from a swine farm near Zagreb, Croatia. The pigs 
were weaned at 4 weeks of age, housed in the animal facility at the Faculty of Veterinary  were weaned at 4 weeks of age, housed in the animal facility at the Faculty of Veterinary 
Medicine, University of Zagreb and fed with a standard weaner diet.  Medicine, University of Zagreb and fed with a standard weaner diet. 
Bacterial strains Bacterial strains.  . The recombinant avirulent vaccine candidate F4ac The recombinant avirulent vaccine candidate F4ac+ + non-ETEC   non-ETEC 
strain 2407 (serotype O9: K36: H19: F4ac: LT strain 2407 (serotype O9: K36: H19: F4ac: LT- - STb  STb- -) kindly donated by dr. sc. Thomas  ) kindly donated by dr. sc. Thomas 
A. Casey from NADC, Ames, IA, USA ( A. Casey from NADC, Ames, IA, USA (CASEY and MOON, 1990 CASEY and MOON, 1990) and attenuated vaccine  ) and attenuated vaccine 
candidate F18ac candidate F18ac+ + non-ETEC strain 2143 (serotype O157:K119:F18ac) kindly donated   non-ETEC strain 2143 (serotype O157:K119:F18ac) kindly donated 
by dr. sc. Bela Nagy from the Veterinary Medical Institute of Hungarian Academy of  by dr. sc. Bela Nagy from the Veterinary Medical Institute of Hungarian Academy of 
Sciences, Budapest, Hungary ( Sciences, Budapest, Hungary (KOVŠCA-JANJATOVIĆ et al., 2009 KOVŠCA-JANJATOVIĆ et al., 2009), were used for the  ), were used for the 
immunization. The authentic F4ac immunization. The authentic F4ac+ + ETEC strain 11-800/1/94 (serotype O19: K91: F4ac:   ETEC strain 11-800/1/94 (serotype O19: K91: F4ac: 
987P: Hly 987P: Hly+ + LT  LT+ + STb  STb+ +), isolated from diarrheic pigs aged between 3 and 4 weeks reared  ), isolated from diarrheic pigs aged between 3 and 4 weeks reared 
on swine farms in Croatia, was used for the challenge infection. Both strains were kept in  on swine farms in Croatia, was used for the challenge infection. Both strains were kept in 
glycerin broth at -80 ºC until used. glycerin broth at -80 ºC until used.
Antibodies. Antibodies.   Mouse IgG1 (clone C-04) monoclonal antibody (mAb), reactive with  Mouse IgG1 (clone C-04) monoclonal antibody (mAb), reactive with 
porcine cytokeratin peptide 18 ( porcine cytokeratin peptide 18 (GEBERT GEBERT et al., 1994  et al., 1994) was used as the primary antibody  ) was used as the primary antibody 
(Biovendor Laboratory Medicine, Heidelberg, Germany). Polyclonal F(ab’) (Biovendor Laboratory Medicine, Heidelberg, Germany). Polyclonal F(ab’)2 2 rabbit anti   rabbit anti 
mouse IgG:HRP antibody (AbD Serotec, Oxford, UK) was used as the secondary antibody.  mouse IgG:HRP antibody (AbD Serotec, Oxford, UK) was used as the secondary antibody. 
To uncover the tissue antigens ﬁ  xed with formalin, stabilized proteolytic enzyme mixture  To uncover the tissue antigens ﬁ  xed with formalin, stabilized proteolytic enzyme mixture 
in an antigen retrieval kit (Abcam, Cambridge, UK) were used prior to the application of  in an antigen retrieval kit (Abcam, Cambridge, UK) were used prior to the application of 
the primary antibody. the primary antibody.
Study design. Study design.   At the age of 4 weeks the pigs were randomly assigned into three  At the age of 4 weeks the pigs were randomly assigned into three 
groups comprising 5 animals each. After 2 days of accommodation, the pigs were treated  groups comprising 5 animals each. After 2 days of accommodation, the pigs were treated 
as follows: (1) control pigs received 5 mL of saline intramuscularly (i.m.) at day 0, (2) the  as follows: (1) control pigs received 5 mL of saline intramuscularly (i.m.) at day 0, (2) the 
pigs from the ﬁ  rst group of principals were i.m. primed with levamisole (Nilverm pigs from the ﬁ  rst group of principals were i.m. primed with levamisole (Nilverm® ®, Pliva,  , Pliva, 
Zagreb, Croatia) at the immunostimulatory dose of 2.5 mg/kg over three consecutive days  Zagreb, Croatia) at the immunostimulatory dose of 2.5 mg/kg over three consecutive days 
(-2, -1, 0) and intragastrically (i.g.) immunized with 10 (-2, -1, 0) and intragastrically (i.g.) immunized with 1010 10 CFU/mL of vaccine candidate   CFU/mL of vaccine candidate 
F4ac F4ac+ + non-ETEC strain 2407 in 60 mL of Trypticase soya bujon (TSB) at day 0, and   non-ETEC strain 2407 in 60 mL of Trypticase soya bujon (TSB) at day 0, and 
(3) the second group of principals received levamisole as aforementioned and was i.g.  (3) the second group of principals received levamisole as aforementioned and was i.g. 81
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vaccinated with 10 vaccinated with 1010 10 CFU/mL of vaccine candidate F18ac  CFU/mL of vaccine candidate F18ac+ + non-ETEC strain 2143 in 60   non-ETEC strain 2143 in 60 
mL of TSB at day 0. Seven days later all pigs were  mL of TSB at day 0. Seven days later all pigs were i.g.  i.g. challenged with 10 challenged with 1010 10 CFU/mL of   CFU/mL of 
F4ac F4ac+ + ETEC strain 11-800/1/94, and 2 from each group were euthanatized at day 13 and   ETEC strain 11-800/1/94, and 2 from each group were euthanatized at day 13 and 
sampled for immunohistology. sampled for immunohistology.
Clinical  observations Clinical observations.  Clinical  observations  for  signs  of  colibacillosis,  such  as  . Clinical observations for signs of colibacillosis, such as 
diarrhea, dehydration, weight loss, weakness and anorexia were recorded three times  diarrhea, dehydration, weight loss, weakness and anorexia were recorded three times 
daily by a person blinded to given treatments. Pigs were weighed at the beginning of the  daily by a person blinded to given treatments. Pigs were weighed at the beginning of the 
trial (day -2), and 7 and 10 days after immunization (at day 0) or 4 days after the challenge  trial (day -2), and 7 and 10 days after immunization (at day 0) or 4 days after the challenge 
infection. The diarrhea developed by pigs was graded on a scale of intensity where scores  infection. The diarrhea developed by pigs was graded on a scale of intensity where scores 
(per pig per day of the experiment) were given based on stool consistency: +, soft feces =  (per pig per day of the experiment) were given based on stool consistency: +, soft feces = 
mild diarrhea; ++, ﬂ  uid feces = moderate diarrhea; +++, watery feces = severe diarrhea.  mild diarrhea; ++, ﬂ  uid feces = moderate diarrhea; +++, watery feces = severe diarrhea. 
Pigs with normal ﬁ  rm feces were scored as diarrhea negative (-). Pigs with normal ﬁ  rm feces were scored as diarrhea negative (-).
Sampling  and  tissue  processing Sampling and tissue processing.  .  Immediately  following  euthanasia  the  samples  Immediately following euthanasia the samples 
of  ileum  were  ﬁ  xed  in  10%  neutral-buffered  formalin  (pH  7.0-7.6)  containing  4%  of ileum were ﬁ   xed in 10% neutral-buffered formalin (pH 7.0-7.6) containing 4% 
formaldehyde  for  24  hours. After  ﬁ  xation  the  tissue  specimens  were  dehydrated  by  formaldehyde for 24 hours. After ﬁ  xation the tissue specimens were dehydrated by 
graded alcohol solutions (in 75%, 80%, 95%, 100% ethanol), washed with xylene as a  graded alcohol solutions (in 75%, 80%, 95%, 100% ethanol), washed with xylene as a 
clearing agent, and incubated in the paraplast embedding medium (Sigma, Deisenhofen,  clearing agent, and incubated in the paraplast embedding medium (Sigma, Deisenhofen, 
Germany). Following incubation, paraplast-embedded specimens were cut into 5-6 μm  Germany). Following incubation, paraplast-embedded specimens were cut into 5-6 μm 
thick serial sections and ﬂ  oated on a water bath containing distilled water, heated to  thick serial sections and ﬂ  oated on a water bath containing distilled water, heated to 
approximately 42 °C. The selected sections were picked up with the precoated slides and  approximately 42 °C. The selected sections were picked up with the precoated slides and 
dried horizontally on a warming tray overnight at 37 °C. dried horizontally on a warming tray overnight at 37 °C.
Immunohistological staining. Immunohistological staining.   Paraplast-embedded ileal specimens were dewaxed in  Paraplast-embedded ileal specimens were dewaxed in 
xylene, hydrated in graded alcohol solutions (in 100%, 100%, 95%, 80%, 75% ethanol)  xylene, hydrated in graded alcohol solutions (in 100%, 100%, 95%, 80%, 75% ethanol) 
and immersed in distilled water. Endogenous peroxidase was blocked with 3% aqueous  and immersed in distilled water. Endogenous peroxidase was blocked with 3% aqueous 
hydrogen peroxide solution for 30 minuntes at room temperature, and nonspeciﬁ  c binding  hydrogen peroxide solution for 30 minuntes at room temperature, and nonspeciﬁ  c binding 
was blocked by 5% rabbit serum and 5% pig serum diluted in phosphate-buffered saline  was blocked by 5% rabbit serum and 5% pig serum diluted in phosphate-buffered saline 
(PBS), for 30 minutes prior to staining. Then the sections were incubated overnight at 4 °C  (PBS), for 30 minutes prior to staining. Then the sections were incubated overnight at 4 °C 
with mouse mAb against cytokeratin peptide 18 (1:50 dilution). The secondary antibody  with mouse mAb against cytokeratin peptide 18 (1:50 dilution). The secondary antibody 
F(ab’) F(ab’)2 2 rabbit anti-mouse IgG HRP conjugate diluted 1:500 in PBS was incubated at   rabbit anti-mouse IgG HRP conjugate diluted 1:500 in PBS was incubated at 
room temperature for 1 hour. The reaction was visualized using a 0.05% solution of 3.3- room temperature for 1 hour. The reaction was visualized using a 0.05% solution of 3.3-
diaminobenzidine tetrachloride (DAB) in 0.05 M Tris-HCl (pH 7.6) containing 0.01%  diaminobenzidine tetrachloride (DAB) in 0.05 M Tris-HCl (pH 7.6) containing 0.01% 
H H2 2O O2 2. The slides were dehydrated by graded alcohol solutions and mounted in canada  . The slides were dehydrated by graded alcohol solutions and mounted in canada 
balsam. balsam.
Histomorphometric analysis. Histomorphometric analysis.   The number of M cells in immunohistologically stained  The number of M cells in immunohistologically stained 
tissue sections of ileum were determined by computer-assisted quantitative analysis. A  tissue sections of ileum were determined by computer-assisted quantitative analysis. A 
light microscope equipped with a video camera was interfaced with a desktop computer  light microscope equipped with a video camera was interfaced with a desktop computer 
containing a live video/computer graphics adapter and commercial imaging Lucia G  containing a live video/computer graphics adapter and commercial imaging Lucia G 
software.  software. 82
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Statistics. Statistics.    Statistical  validation  was  performed  on  12  randomly  selected  digital  Statistical validation was performed on 12 randomly selected digital 
image ﬁ  elds of an average area of 700480 μm image ﬁ  elds of an average area of 700480 μm2 2 per 5 tissue sections of 2 pigs from three   per 5 tissue sections of 2 pigs from three 
experimental groups. Antecedent testing showed that when more than 10 ﬁ  elds in each  experimental groups. Antecedent testing showed that when more than 10 ﬁ  elds in each 
of the 5 tissue samples from one pig per group were analyzed there were no signiﬁ  cant  of the 5 tissue samples from one pig per group were analyzed there were no signiﬁ  cant 
deviations in the cell counts of individual pig. Levels of signiﬁ  cance of differences  deviations in the cell counts of individual pig. Levels of signiﬁ  cance of differences 
between principal and control pigs were determined by the two-tailed Student’s  between principal and control pigs were determined by the two-tailed Student’s t t-test.  -test. 
The results deviating from the null hypothesis at a level of P<0.01 were considered as  The results deviating from the null hypothesis at a level of P<0.01 were considered as 
signiﬁ  cant. signiﬁ  cant.
Results Results
Clinical ﬁ  ndings.  Clinical ﬁ  ndings. None of the pigs developed signs of colidiarrhea, and all were  None of the pigs developed signs of colidiarrhea, and all were 
clinically normal at the time of treatment. The mean weight (kg ± SD) of pigs per group  clinically normal at the time of treatment. The mean weight (kg ± SD) of pigs per group 
at day -2 were: control = 7.40 ± 0.6; levamisole-pretreated F4ac at day -2 were: control = 7.40 ± 0.6; levamisole-pretreated F4ac+ + non-ETEC-immunized/  non-ETEC-immunized/
challenged  =  6.68  ±  0.8;  and  levamisole-pretreated  F18ac challenged = 6.68 ± 0.8; and levamisole-pretreated F18ac+ +  non-ETEC-immunized/  non-ETEC-immunized/
challenged = 6.50 ± 0.8. All these body weights were statistically similar. Seven days  challenged = 6.50 ± 0.8. All these body weights were statistically similar. Seven days 
following the treatment, levamisole-pretreated F4ac following the treatment, levamisole-pretreated F4ac+ + non-ETEC-immunized/challenged  non-ETEC-immunized/challenged   
pigs had lower (P<0.05) body weight (5.93 ± 0.5) as compared to that in control pigs (7.75  pigs had lower (P<0.05) body weight (5.93 ± 0.5) as compared to that in control pigs (7.75 
± 1.0). Weight gain in levamisole-pretreated ± 1.0). Weight gain in levamisole-pretreated   F18ac F18ac+ + non-ETEC-immunized  non-ETEC-immunized/ /challenged  challenged 
pigs was slightly (7.32 ± 0.9) but not signiﬁ  cantly lower. Ten days after the treatment,  pigs was slightly (7.32 ± 0.9) but not signiﬁ  cantly lower. Ten days after the treatment, 
average group weights were similar and none of them differ from the corresponding  average group weights were similar and none of them differ from the corresponding 
weight on day -2. In the control and levamisole-pretreated F18ac weight on day -2. In the control and levamisole-pretreated F18ac+ + non-ETEC-immunized/  non-ETEC-immunized/
challenged pigs body weights were slightly, but not signiﬁ  cantly increased (8.68 ± 1.0 and  challenged pigs body weights were slightly, but not signiﬁ  cantly increased (8.68 ± 1.0 and 
7.40 ± 0.5, respectively). Levamisole-pretreated F4ac 7.40 ± 0.5, respectively). Levamisole-pretreated F4ac+ + non-ETEC-immunized/challenged   non-ETEC-immunized/challenged 
pigs gained weight much faster as compared to day 7 (7.75 ± 0,5) but this increase was  pigs gained weight much faster as compared to day 7 (7.75 ± 0,5) but this increase was 
not signiﬁ  cantly higher than their weight at day -2. Two of the ﬁ  ve control pigs became  not signiﬁ  cantly higher than their weight at day -2. Two of the ﬁ  ve control pigs became 
diarrheic three days after the treatment (at day 3) and the third pig developed moderate  diarrheic three days after the treatment (at day 3) and the third pig developed moderate 
diarrhea at day 4 (Table 1).  diarrhea at day 4 (Table 1). 
The diarrhea, ranging from mild to severe continued for three to ﬁ  ve days. Transient  The diarrhea, ranging from mild to severe continued for three to ﬁ  ve days. Transient 
diarrhea  was  apparent  in  two  levamisole-pretreated  F4ac diarrhea was apparent in two levamisole-pretreated F4ac+ +  non-ETEC-immunized/  non-ETEC-immunized/
challenged pig at days 3 and 7 after the treatment, whereas the other three pigs were in  challenged pig at days 3 and 7 after the treatment, whereas the other three pigs were in 
poor health and feeding condition during the entire study period. poor health and feeding condition during the entire study period.   Two of them developed  Two of them developed 
moderate to severe diarrhea at day 1 and one died at day 3. The third pig developed  moderate to severe diarrhea at day 1 and one died at day 3. The third pig developed 
moderate diarrhea at day 2, which continued in a milder form until day 7. Two of three  moderate diarrhea at day 2, which continued in a milder form until day 7. Two of three 
diarrheic  pigs  in  the  levamisole-pretreated  F18ac diarrheic pigs in the levamisole-pretreated F18ac+ +  non-ETEC-immunized/challenged   non-ETEC-immunized/challenged 
group developed mild diarrhea at day 3, but recovered shortly. The third pig developed  group developed mild diarrhea at day 3, but recovered shortly. The third pig developed 
moderate diarrhea at day 1 and remained diarrheic until day 8 of the experiment. As in  moderate diarrhea at day 1 and remained diarrheic until day 8 of the experiment. As in 
both vaccinated groups 4 of 8 diarrheic pigs developed diarrhea at day 1 or day 2, we  both vaccinated groups 4 of 8 diarrheic pigs developed diarrhea at day 1 or day 2, we 
assume that it was a consequence of natural infection rather than the vaccination.  assume that it was a consequence of natural infection rather than the vaccination. 83
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Table 1. Extent of diarrhea intensity expressed as scores based on stools consistency: -, ﬁ  rm feces  Table 1. Extent of diarrhea intensity expressed as scores based on stools consistency: -, ﬁ  rm feces 
= no diarrhea; +, soft feces = mild diarrhea; ++, ﬂ  uid feces = moderate diarrhea; +++, watery  = no diarrhea; +, soft feces = mild diarrhea; ++, ﬂ  uid feces = moderate diarrhea; +++, watery 
feces = severe diarrhea. feces = severe diarrhea.
Treatment of pigsa Pig No.
Day of experiment
12345678 9-13
Salineb/
F4ac+ ETEC
1
2 ++ ++ +++ ++ ++
3+ + + +
4+ + + +
5
Levamisole +
F4ac+ non-ETEC/
F4ac+ ETEC
1 + + +++ +
2+ +
3 ++ ++ +++ ++ ++ ++
4 +++ +++ c
5+ +
Levamisole + 
F18ac+non-ETEC/
F4ac+ ETEC
1+
2 + ++ ++ + + + + +
3
4
5+ +
a  a Groups comprised ﬁ  ve 4-weeks-old pigs each.  Groups comprised ﬁ  ve 4-weeks-old pigs each. b bControl pigs received saline as a placebo.  Control pigs received saline as a placebo. c cDied at day 3 due  Died at day 3 due 
to diarrheal disease.  to diarrheal disease. 
Immunohistological  ﬁ  ndings Immunohistological  ﬁ  ndings.  Immunohistological  identiﬁ  cation  of  cytokeratin  . Immunohistological identiﬁ   cation of cytokeratin 
peptide 18 peptide 18+ + M cells within the villous epithelium of the ileum of the weaned pigs is shown   M cells within the villous epithelium of the ileum of the weaned pigs is shown 
in Figs. 1, 2 and 3. It is visible that M cells were quite scarce in the villous epithelium  in Figs. 1, 2 and 3. It is visible that M cells were quite scarce in the villous epithelium 
of the ileum of the control nonpretreated and challenged pig (Fig. 1). Similarly as in  of the ileum of the control nonpretreated and challenged pig (Fig. 1). Similarly as in 
the control nonpretreated and challenged pigs, these cells were rarely scattered in the  the control nonpretreated and challenged pigs, these cells were rarely scattered in the 
villous  epithelium  of  ileum  of  levamisole-primed  F4ac villous epithelium of ileum of levamisole-primed F4ac+ +  non-ETEC-vaccinated  and   non-ETEC-vaccinated and 
challenged pigs (Fig. 2). On the other hand, numerous M cells were found within the  challenged pigs (Fig. 2). On the other hand, numerous M cells were found within the 
villous epithelium of ileum of levamisole-pretreated F4ac villous epithelium of ileum of levamisole-pretreated F4ac+ + non-ETEC-immunized and   non-ETEC-immunized and 
challenged pigs (Fig. 3). Generally, the M cells are rather solitarily interspersed between  challenged pigs (Fig. 3). Generally, the M cells are rather solitarily interspersed between 
enterocytes rather than as small clusters (Figs. 1, 2 and 3), and most of them were found  enterocytes rather than as small clusters (Figs. 1, 2 and 3), and most of them were found 
to be located at the apex of the villi in 6-week-old pigs.  to be located at the apex of the villi in 6-week-old pigs. 84
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Fig. 3. Cytokeratin peptide 18+ M cells in ileal villous epithelium of levamisole-primed (at days 
-2,-1 and 0 i.m. received the drug) F18ac+ non-ETEC-immunized (i.g. at day 0) and challenged 
(at day 7 i.g. received pathogenic F4ac+ ETEC strain) pig aging 6 weeks; original magniﬁ  cation 
×400.
Fig. 1. Cytokeratin peptide 18+ M cells in ileal 
villous epithelium of control (at day 0 i.m. 
received saline as a placebo) and challenged 
(at day 7 perorally received pathogenic F4ac+ 
ETEC strain) pig aging 6 weeks; original 
magniﬁ  cation ×400.
Fig. 2. Cytokeratin peptide 18+ M cells in ileal 
villous epithelium of levamisole-primed (at 
days -2,-1 and 0 i.m. received the drug) F4ac+ 
non-ETEC-immunized (i.g. at day 0) and 
challenged (at day 7 i.g. received pathogenic 
F4ac+ ETEC strain) pig aging 6 weeks; 
original magniﬁ  cation ×400.
Histomorphometric ﬁ  ndings. Histomorphometric ﬁ  ndings. Numerical data on the ileal M cells of the pigs from   Numerical data on the ileal M cells of the pigs from 
three experimental groups, as determined by computer-assisted morphometric analyses  three experimental groups, as determined by computer-assisted morphometric analyses 
are shown in Table 2. Also, the proportions of M cells are expressed as a ratio between  are shown in Table 2. Also, the proportions of M cells are expressed as a ratio between 
number of M cells in the principal groups (no. increased or decreased) and that in the  number of M cells in the principal groups (no. increased or decreased) and that in the 
control group (where the number of cells = 100% or 1.00). Quantitative phenotypic  control group (where the number of cells = 100% or 1.00). Quantitative phenotypic 85
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analyses showed that levamisole-pretreated F18ac analyses showed that levamisole-pretreated F18ac+ +non-ETEC-immunized and challenged  non-ETEC-immunized and challenged 
pigs had signiﬁ  cantly increased number (P<0.01) of ileal M cells as compared to the  pigs had signiﬁ  cantly increased number (P<0.01) of ileal M cells as compared to the 
values obtained from the control nonprimed and challenged pigs. The proportion of these  values obtained from the control nonprimed and challenged pigs. The proportion of these 
cells in this group of pigs was increased by 145%. In the levamisole-pretreated F4ac cells in this group of pigs was increased by 145%. In the levamisole-pretreated F4ac+ +   
non-ETEC-immunized and challenged pigs only a slightly increased (for 7%) proportion  non-ETEC-immunized and challenged pigs only a slightly increased (for 7%) proportion 
of M cells was recorded. However, this increase was not signiﬁ  cantly different from the  of M cells was recorded. However, this increase was not signiﬁ  cantly different from the 
numerical values obtained for the control pigs.  numerical values obtained for the control pigs. 
Table 2. Numerical values of cytokeratin peptide 18 Table 2. Numerical values of cytokeratin peptide 18+ + M cells in villous epithelium of the ileum   M cells in villous epithelium of the ileum 
from pigs primed with levamisole (days -2, -1 and 0) and immunized with either F4ac from pigs primed with levamisole (days -2, -1 and 0) and immunized with either F4ac+ + or F18ac  or F18ac+ +   
non-ETEC vaccine candidate strains (day 0) and challenged with F4ac non-ETEC vaccine candidate strains (day 0) and challenged with F4ac+ + ETEC strain (day 7); the   ETEC strain (day 7); the 
results are expressed as mean values and standard deviations (M ± SD) of number of the cells per  results are expressed as mean values and standard deviations (M ± SD) of number of the cells per 
μm μm2 2 of tissue section ﬁ  eld.  of tissue section ﬁ  eld.
Treatmenta
M ± SD number of ileal M cells in 
6-weeks-old pigsb Index c
Increase/
decrease
Noned + 
F4ac+ ETEC 6.12 × 10-5 ± 9.44 × 10-6 1.00 /
Levamisole + F4ac+ non-
ETEC + F4ac+ ETEC 6.53 × 10-5 ± 9.90 × 10-6 1.07 + 0.07
Levamisole + F18ac+ 
non-ETEC + F4ac+ ETEC 1.50 × 10-4 ± 5.74 × 10-5 * 2.45 + 1.45
a aGroups comprised ﬁ  ve 4-week-old pigs each.  Groups comprised ﬁ  ve 4-week-old pigs each. b bAs counted in 12 randomly selected ﬁ  elds of the average area  As counted in 12 randomly selected ﬁ  elds of the average area 
of 700480 μm of 700480 μm2 2 per sample from 2 pigs (euthanatized at day 13) per group.  per sample from 2 pigs (euthanatized at day 13) per group.c cRatio between no. of M cells in the  Ratio between no. of M cells in the 
principal groups and that (no. of the cells = 100% or 1.00) in the control group.  principal groups and that (no. of the cells = 100% or 1.00) in the control group. d dControl pigs received saline at  Control pigs received saline at 
day 0 as a placebo.*Signiﬁ  cantly higher (P<0.01) than in the control pigs. vv day 0 as a placebo.*Signiﬁ  cantly higher (P<0.01) than in the control pigs. vv
Discussion Discussion
This study demonstrates that (1): cytokeratin 18 peptide, as a speciﬁ  c marker for  This study demonstrates that (1): cytokeratin 18 peptide, as a speciﬁ  c marker for 
porcine M cells residing the FAE region ( porcine M cells residing the FAE region (GEBERT et al., 1994 GEBERT et al., 1994) also enabled us to identify  ) also enabled us to identify 
these cells within the villous epithelium of the ileum of 6-week-old pigs, regardless of  these cells within the villous epithelium of the ileum of 6-week-old pigs, regardless of 
the treatments applied; (2) porcine intestinal villous M cells probably originated from the treatments applied; (2) porcine intestinal villous M cells probably originated from   
immature enterocytes upon exposure to foreign antigens or pathogens (such as ﬁ  mbrial  immature enterocytes upon exposure to foreign antigens or pathogens (such as ﬁ  mbrial 
and/or  toxin  antigens  of  either  non-ETEC  or  ETEC  strains  applied,  respectively),  and/or toxin antigens of either non-ETEC or ETEC strains applied, respectively), 
as postulated for rodents and humans ( as postulated for rodents and humans (JANG et al., 2004 JANG et al., 2004), (3) the M cells are solitarily  ), (3) the M cells are solitarily 
interspersed between ileal enterocytes rather than as small clusters, and most of them  interspersed between ileal enterocytes rather than as small clusters, and most of them 
were found to be located at the apex of the villi, (4) levamisole-adjuvanted F18ac were found to be located at the apex of the villi, (4) levamisole-adjuvanted F18ac+ +non- non-
ETEC vaccine affected  ETEC vaccine affected de novo de novo differentiation of M cells by increasing their number   differentiation of M cells by increasing their number 
in the villous epithelium of the ileum, whereas levamisole-adjuvanted F4ac in the villous epithelium of the ileum, whereas levamisole-adjuvanted F4ac+ +non-ETEC  non-ETEC 
vaccine failed to produce the same effect, (5) vaccine candidate F18ac vaccine failed to produce the same effect, (5) vaccine candidate F18ac+  + non-ETEC strain  non-ETEC strain 
probably utilizes M cells as a target for entry/delivery to the nearby lymphocytes, which  probably utilizes M cells as a target for entry/delivery to the nearby lymphocytes, which 86
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is a prerequisite for induction of the intestinal immune responses, and (6) F4ac is a prerequisite for induction of the intestinal immune responses, and (6) F4ac+ +-ETEC  -ETEC 
challenge strain acted synergistically rather than competitively with non-homologous  challenge strain acted synergistically rather than competitively with non-homologous 
vaccinal strain on the increased rate of  vaccinal strain on the increased rate of de novo de novo formation of M cells in weaned pigs. It   formation of M cells in weaned pigs. It 
is well known that non-adherent antigens are frequently poorly internalized by M cells  is well known that non-adherent antigens are frequently poorly internalized by M cells 
and hence generally induce weak immune responses or even tolerance ( and hence generally induce weak immune responses or even tolerance (BELYAKOV et  BELYAKOV et 
al., 2004 al., 2004). The failure of levamisole-adjuvanted F4ac ). The failure of levamisole-adjuvanted F4ac+ +non-ETEC vaccine to produce a  non-ETEC vaccine to produce a 
similar effect on M cells as levamisole-adjuvanted F18ac similar effect on M cells as levamisole-adjuvanted F18ac+ +non-ETEC vaccine did, could  non-ETEC vaccine did, could 
be explained by its competition for the same enterocyte receptors with F4ac be explained by its competition for the same enterocyte receptors with F4ac+ +-ETEC  -ETEC 
challenge strain, which resulted in ﬂ  ushing of nonadherent bacteria by peristaltic. Such  challenge strain, which resulted in ﬂ  ushing of nonadherent bacteria by peristaltic. Such 
adhesion is a prerequisite for stimulation of the intestinal mucosal immunity preceded by  adhesion is a prerequisite for stimulation of the intestinal mucosal immunity preceded by 
development of M cells from enterocytes upon exposure to enteric pathogens ( development of M cells from enterocytes upon exposure to enteric pathogens (JANG et  JANG et 
al., 2004 al., 2004), such as the F4ac ), such as the F4ac+ + ETEC strain. Indeed, it was recently shown that it is possible   ETEC strain. Indeed, it was recently shown that it is possible 
to differentiate the intestinal immune responses of pigs immunized with levamisole- to differentiate the intestinal immune responses of pigs immunized with levamisole-
adjuvanted experimental mucosal vaccines against postweaning CE and CD from those  adjuvanted experimental mucosal vaccines against postweaning CE and CD from those 
of non-immunized pigs ( of non-immunized pigs (KOVŠCA JANJATOVIĆ et al., KOVŠCA JANJATOVIĆ et al.,   2009; KOVŠCA  2009; KOVŠCA JANJATOVIĆ  JANJATOVIĆ et al et al.,  ., 
2010 2010). Also, we have more recently demonstrated that levamisole, already recognized as  ). Also, we have more recently demonstrated that levamisole, already recognized as 
a potent immunomodulator/adjuvant ( a potent immunomodulator/adjuvant (BOŽIĆ et. al., 2006; JANJATOVIĆ et al., 2008 BOŽIĆ et. al., 2006; JANJATOVIĆ et al., 2008) may  ) may 
inﬂ  uence the  inﬂ  uence the de novo de novo differentiation of M cells, by increasing their number in the ileum   differentiation of M cells, by increasing their number in the ileum 
of weaned pigs ( of weaned pigs (VALPOTIĆ et al., 2010 VALPOTIĆ et al., 2010). This ﬁ  nding makes levamisole an interesting  ). This ﬁ  nding makes levamisole an interesting 
adjuvant to study development of the effective M cell-targeted vaccines against porcine  adjuvant to study development of the effective M cell-targeted vaccines against porcine 
post-weaning CD and/or CE post-weaning CD and/or CE   in order to circumvent weak or tolerogenic responses in order to circumvent weak or tolerogenic responses   to  to 
orally applied  orally applied E. coli E. coli vaccines as described earlier (  vaccines as described earlier (FRANCIS and WILLGOHS, 1991 FRANCIS and WILLGOHS, 1991). It is  ). It is 
now recognized that levamisole-adjuvanted live oral F4ac now recognized that levamisole-adjuvanted live oral F4ac+ + non-ETEC vaccine induced   non-ETEC vaccine induced 
both intestinal secretory ( both intestinal secretory (JANJATOVIĆ et al., 2008 JANJATOVIĆ et al., 2008) and cellular immunity ( ) and cellular immunity (BOŽIĆ  BOŽIĆ et al.,  et al., 
2006 2006), offering solid protection to pigs vaccinated against CD. ), offering solid protection to pigs vaccinated against CD.
Since the M cells play a central role in initiation of the intestinal immune responses,  Since the M cells play a central role in initiation of the intestinal immune responses, 
it has been postulated that cross talk between these cells, and underlying dendritic cells  it has been postulated that cross talk between these cells, and underlying dendritic cells 
and lymphocytes is crucial for determining the outcome of protective immune responses  and lymphocytes is crucial for determining the outcome of protective immune responses 
versus versus tolerogenic responses (  tolerogenic responses (EL BAHI et al., 2002; MILLER et al., 2007 EL BAHI et al., 2002; MILLER et al., 2007).  ). MIYAZAWA et  MIYAZAWA et 
al. (2006) al. (2006) suggested that committed M cells differentiate to mature M cells by contact   suggested that committed M cells differentiate to mature M cells by contact 
with lymphocytes at the FAE periphery. with lymphocytes at the FAE periphery.   As it has been recognized that lymphoepithelial  As it has been recognized that lymphoepithelial 
interactions and soluble factors provide important signals for differentiation of M cells  interactions and soluble factors provide important signals for differentiation of M cells 
( (NEUTRA et al., 2001; EL BACHI et al., 2002 NEUTRA et al., 2001; EL BACHI et al., 2002), it would be reasonable to assume that  ), it would be reasonable to assume that 
levamisole-adjuvented F18ac levamisole-adjuvented F18ac+ +non-ETEC vaccine candidate strain might inﬂ  uence  non-ETEC vaccine candidate strain might inﬂ  uence de novo de novo   
formation of porcine intestinal villous M cell phenotype by stimulating the activation of  formation of porcine intestinal villous M cell phenotype by stimulating the activation of 
lymphocyte subsets in the lamina propria and Peyer’s patches of weaned pigs as we have  lymphocyte subsets in the lamina propria and Peyer’s patches of weaned pigs as we have 
reported earlier ( reported earlier (BOŽIĆ et al BOŽIĆ et al. ., 2003a, b; BOŽIĆ et al., 2006; KOVŠCA JANJATOVIĆ et al.,  , 2003a, b; BOŽIĆ et al., 2006; KOVŠCA JANJATOVIĆ et al., 
2009 2009). It is very likely that levamisole is a crucial agent for such up-regulation of M cells  ). It is very likely that levamisole is a crucial agent for such up-regulation of M cells 
proliferation since the drug when given alone produced similar effect in this model system  proliferation since the drug when given alone produced similar effect in this model system 
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( (VALPOTIĆ et al., 2010 VALPOTIĆ et al., 2010). However, the interaction between levamisole-adjuvanted F4ac ). However, the interaction between levamisole-adjuvanted F4ac+ +   
non-ETEC vaccine and porcine intestinal villous M cells did not result in up-regulated  non-ETEC vaccine and porcine intestinal villous M cells did not result in up-regulated 
proliferation of these cells. The main reason for this differences seen among two non- proliferation of these cells. The main reason for this differences seen among two non-
ETEC strains might be the presence or absence of M cell-targeting gene products,  ETEC strains might be the presence or absence of M cell-targeting gene products, i.e i.e.  . 
the long polar ﬁ  mbria which play important role in the selective adherence of  the long polar ﬁ  mbria which play important role in the selective adherence of E. coli E. coli to   to 
M cells. For example, the rabbit diarrheagenic  M cells. For example, the rabbit diarrheagenic E. coli E. coli-1 strain is selective for adherence  -1 strain is selective for adherence 
to M cells ( to M cells (GEBERT et al., 1996 GEBERT et al., 1996), whereas enteropathogenic  ), whereas enteropathogenic E. coli  E. coli is not transcytosed by  is not transcytosed by 
the M cells and remains in the gut lumen ( the M cells and remains in the gut lumen (SIEBERS and FINLAY, 1996 SIEBERS and FINLAY, 1996). Accordingly, it  ). Accordingly, it 
seems likely that F4ac seems likely that F4ac+ + non-ETEC strain did not readily attach to the M cells, and thus,   non-ETEC strain did not readily attach to the M cells, and thus, 
was not able to stimulate their proliferation as F18ac was not able to stimulate their proliferation as F18ac+ +non-ETEC strain did. Indeed, the  non-ETEC strain did. Indeed, the 
former former E. coli   E. coli strain failed to stimulate increased proliferation of M cells when given  strain failed to stimulate increased proliferation of M cells when given 
alone ( alone (VALPOTIĆ VALPOTIĆ et al., 2010  et al., 2010) or in the combination with levamisole as an adjuvant.  ) or in the combination with levamisole as an adjuvant. 
It is concluded that levamisole-adjuvanted F18ac It is concluded that levamisole-adjuvanted F18ac+ +non-ETEC vaccine may affect  non-ETEC vaccine may affect de  de 
novo novo differentiation of porcine M cells by increasing their number in the ileal villous   differentiation of porcine M cells by increasing their number in the ileal villous 
epithelium, indicated that the vaccine probably utilizes these cells as a target for entry/ epithelium, indicated that the vaccine probably utilizes these cells as a target for entry/
delivery to underlying lymphocytes and induces protective mucosal immunity against  delivery to underlying lymphocytes and induces protective mucosal immunity against 
CE. Since the intestinal villous M cells are functionally analogous to the FAE-residing M  CE. Since the intestinal villous M cells are functionally analogous to the FAE-residing M 
cells ( cells (JANG et al., 2004 JANG et al., 2004) and may compensate for their functions independently of Peyer’s  ) and may compensate for their functions independently of Peyer’s 
patches, we assume that our ﬁ  nding of up-regulated proliferation of these cells following  patches, we assume that our ﬁ  nding of up-regulated proliferation of these cells following 
the inoculation of weaned pigs with adjuvanted-vaccine against porcine postweaning CE  the inoculation of weaned pigs with adjuvanted-vaccine against porcine postweaning CE 
might be of relevance to the process of delivery to the immune cells populating intestinal  might be of relevance to the process of delivery to the immune cells populating intestinal 
lamina propria as well as to its immunogenicity/protective ability.  lamina propria as well as to its immunogenicity/protective ability. 
_______ _______
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SAŽETAK SAŽETAK
Aktivna imunizacija odbijene prasadi protiv kolidijareje (KD) i/ili kolienterotoksemije (KE) uzrokovane  Aktivna imunizacija odbijene prasadi protiv kolidijareje (KD) i/ili kolienterotoksemije (KE) uzrokovane 
F4ac+  i/ili  F18ac+  enterotoksigenim  sojevima  bakterije  F4ac+ i/ili F18ac+ enterotoksigenim sojevima bakterije Escherichia  coli Escherichia coli  (ETEC)  još  je  uvijek  neriješen   (ETEC) još je uvijek neriješen 
problem. Crijevne mikronaborane (M) stanice imaju funkciju pri ulasku/invaziji intraluminalnih patogena (kao  problem. Crijevne mikronaborane (M) stanice imaju funkciju pri ulasku/invaziji intraluminalnih patogena (kao 
što su ETEC sojevi), unosu uzoraka antigena i pogodovanju tvorbi imunosti na probavne infekcije. Činjenica  što su ETEC sojevi), unosu uzoraka antigena i pogodovanju tvorbi imunosti na probavne infekcije. Činjenica 
da ETEC sojevi rabe M stanice kao ulazna vrata za uzročnike infekcija, kao što su KD i/ili KE, a njihova velika  da ETEC sojevi rabe M stanice kao ulazna vrata za uzročnike infekcija, kao što su KD i/ili KE, a njihova velika 
sposobnost transcitoze čini ih ujedno pogodnim stanicama za unos mukoznih cjepiva, adjuvanata i lijekova. Cilj  sposobnost transcitoze čini ih ujedno pogodnim stanicama za unos mukoznih cjepiva, adjuvanata i lijekova. Cilj 
ovoga rada bilo je vrednovanje učinaka pokusnih cjepnih sojeva F4ac ovoga rada bilo je vrednovanje učinaka pokusnih cjepnih sojeva F4ac+ + i F18ac  i F18ac+ + ne-ETEC, s levamisolom kao   ne-ETEC, s levamisolom kao 
adjuvansom, na pojavnost i brojnost M stanica u ileumu, te na poticanje unosa antigena nakon  adjuvansom, na pojavnost i brojnost M stanica u ileumu, te na poticanje unosa antigena nakon de novo de novo tvorbe   tvorbe 
tih stanica u odbijene prasadi. Prasad iz uobičajenoga uzgoja, u dobi od 4 tjedna, bila je razvrstana u tri skupine  tih stanica u odbijene prasadi. Prasad iz uobičajenoga uzgoja, u dobi od 4 tjedna, bila je razvrstana u tri skupine 
od kojih su dvije parenteralno/oralno imunizirane levamisolom (-2., -1. i 0. dana pokusa) u kombinaciji s jednim  od kojih su dvije parenteralno/oralno imunizirane levamisolom (-2., -1. i 0. dana pokusa) u kombinaciji s jednim 
od dva pokusna vakcinalna ne-ETEC soja (0. dana pokusa). Treća je skupina primila ﬁ  ziološku otopinu kao  od dva pokusna vakcinalna ne-ETEC soja (0. dana pokusa). Treća je skupina primila ﬁ  ziološku otopinu kao 
placebo. Izazivačka je infekcija provedena s F4ac placebo. Izazivačka je infekcija provedena s F4ac+ + ETEC sojem (7. dana pokusa), a prasad je usmrćena (13.   ETEC sojem (7. dana pokusa), a prasad je usmrćena (13. 
dana pokusa) radi uzimanja uzoraka za imunohistologiju. Distribucijski obrasci M stanica, pozitivnih na biljeg  dana pokusa) radi uzimanja uzoraka za imunohistologiju. Distribucijski obrasci M stanica, pozitivnih na biljeg 
za citokeratin 18, pokazuju da su pretežito raspršene između enterocita, a manje ih je u malim nakupinama, te  za citokeratin 18, pokazuju da su pretežito raspršene između enterocita, a manje ih je u malim nakupinama, te 
da se većina tih stanica nalazi pri vrhu resica ileuma prasadi u dobi od 6 tjedana. Morfometrijska kvantiﬁ  kacija  da se većina tih stanica nalazi pri vrhu resica ileuma prasadi u dobi od 6 tjedana. Morfometrijska kvantiﬁ  kacija 
M stanica u sluznici ileuma pokazuje da prasad koja je prethodno dobivala levamisol i imunizirana F18ac+ ne- M stanica u sluznici ileuma pokazuje da prasad koja je prethodno dobivala levamisol i imunizirana F18ac+ ne-
ETEC sojem ima značajno veći broj (P<0,01) M stanica u usporedbi s vrijednostima dobivenima u kontrolne  ETEC sojem ima značajno veći broj (P<0,01) M stanica u usporedbi s vrijednostima dobivenima u kontrolne 
neimunizirane prasadi. Udjel M stanica u te prasadi bio je povećan za 145%. U skupini prasadi prethodno  neimunizirane prasadi. Udjel M stanica u te prasadi bio je povećan za 145%. U skupini prasadi prethodno 
obrađene levamisolom i imuniziranih F4ac obrađene levamisolom i imuniziranih F4ac+ + ne-ETEC sojem zabilježen je samo blagi porast (za 7%) udjela M   ne-ETEC sojem zabilježen je samo blagi porast (za 7%) udjela M 
stanica. Međutim, taj porast nije bio statistički značajno različit od vrijednosti dobivenih u kontrolne prasadi.  stanica. Međutim, taj porast nije bio statistički značajno različit od vrijednosti dobivenih u kontrolne prasadi. 
Naš nalaz da F18ac Naš nalaz da F18ac+ + ne-ETEC vakcina s levamisolom kao adjuvansom može pospješiti   ne-ETEC vakcina s levamisolom kao adjuvansom može pospješiti de novo de novo diferencijaciju   diferencijaciju 
M stanica time što povećava njihovu brojnost u ileumu, upućuje na povećanu sposobnost tih stanica da unose  M stanica time što povećava njihovu brojnost u ileumu, upućuje na povećanu sposobnost tih stanica da unose 
pokusni vakcinalni soj i tako dostavljaju imunogen do obližnjih limfocita što potiče zaštitnu imunost protiv KE.  pokusni vakcinalni soj i tako dostavljaju imunogen do obližnjih limfocita što potiče zaštitnu imunost protiv KE. 
Međutim, trebalo bi objasniti izostanak sličnog učinka na M stanice u prasadi koja je primila F4ac Međutim, trebalo bi objasniti izostanak sličnog učinka na M stanice u prasadi koja je primila F4ac+ + ne-ETEC   ne-ETEC 
vakcinu s levamisolom kao adjuvansom.  vakcinu s levamisolom kao adjuvansom. 
Ključne riječi:  Ključne riječi: M stanice, adjuvantnost levamisola,  M stanice, adjuvantnost levamisola, E. coli E. coli, vakcine, odbijena prasad , vakcine, odbijena prasad
Received: 22 February 2010
Accepted: 29 October 2010
Vet. arhiv 81 (1), 77-90, 2011